These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25058934)

  • 1. Human health risk assessment of the mixture of pharmaceuticals in Dutch drinking water and its sources based on frequent monitoring data.
    Houtman CJ; Kroesbergen J; Lekkerkerker-Teunissen K; van der Hoek JP
    Sci Total Environ; 2014 Oct; 496():54-62. PubMed ID: 25058934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water.
    de Jongh CM; Kooij PJ; de Voogt P; ter Laak TL
    Sci Total Environ; 2012 Jun; 427-428():70-7. PubMed ID: 22551934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health related guide values for drinking-water since 1993 as guidance to assess presence of new analytes in drinking-water.
    Dieter HH
    Int J Hyg Environ Health; 2014 Mar; 217(2-3):117-32. PubMed ID: 23820379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of pharmaceuticals in a water supply system and related human health risk assessment.
    de Jesus Gaffney V; Almeida CM; Rodrigues A; Ferreira E; Benoliel MJ; Cardoso VV
    Water Res; 2015 Apr; 72():199-208. PubMed ID: 25453834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect human exposure to pharmaceuticals via drinking water.
    Webb S; Ternes T; Gibert M; Olejniczak K
    Toxicol Lett; 2003 May; 142(3):157-67. PubMed ID: 12691710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological risk assessment and prioritization of drinking water relevant contaminants of emerging concern.
    Baken KA; Sjerps RMA; Schriks M; van Wezel AP
    Environ Int; 2018 Sep; 118():293-303. PubMed ID: 29909348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence and human health risk of wastewater-derived pharmaceuticals in a drinking water source for Shanghai, East China.
    Wen ZH; Chen L; Meng XZ; Duan YP; Zhang ZS; Zeng EY
    Sci Total Environ; 2014 Aug; 490():987-93. PubMed ID: 24914528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of selected pharmaceuticals at drinking water purification plants in Japan and implications for human health.
    Simazaki D; Kubota R; Suzuki T; Akiba M; Nishimura T; Kunikane S
    Water Res; 2015 Jun; 76():187-200. PubMed ID: 25835589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of pharmaceutical residues in drinking water in Poland using a new SPE-GC-MS(SIM) method based on Speedisk extraction disks and DIMETRIS derivatization.
    Caban M; Lis E; Kumirska J; Stepnowski P
    Sci Total Environ; 2015 Dec; 538():402-11. PubMed ID: 26318224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the "threshold of toxicological concern" to derive tolerable concentrations of "non-relevant metabolites" formed from plant protection products in ground and drinking water.
    Melching-Kollmuss S; Dekant W; Kalberlah F
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):126-34. PubMed ID: 19766683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence, removal and seasonal variation of pharmaceuticals in Brasilian drinking water treatment plants.
    Reis EO; Foureaux AFS; Rodrigues JS; Moreira VR; Lebron YAR; Santos LVS; Amaral MCS; Lange LC
    Environ Pollut; 2019 Jul; 250():773-781. PubMed ID: 31039472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmaceuticals, perfluorosurfactants, and other organic wastewater compounds in public drinking water wells in a shallow sand and gravel aquifer.
    Schaider LA; Rudel RA; Ackerman JM; Dunagan SC; Brody JG
    Sci Total Environ; 2014 Jan; 468-469():384-93. PubMed ID: 24055660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide reconnaissance of contaminants of emerging concern in source and treated drinking waters of the United States: Pharmaceuticals.
    Furlong ET; Batt AL; Glassmeyer ST; Noriega MC; Kolpin DW; Mash H; Schenck KM
    Sci Total Environ; 2017 Feb; 579():1629-1642. PubMed ID: 28040194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicological relevance of pharmaceuticals in drinking water.
    Bruce GM; Pleus RC; Snyder SA
    Environ Sci Technol; 2010 Jul; 44(14):5619-26. PubMed ID: 20575537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pharmaceuticals in US surface waters: a human health risk assessment.
    Schwab BW; Hayes EP; Fiori JM; Mastrocco FJ; Roden NM; Cragin D; Meyerhoff RD; D'Aco VJ; Anderson PD
    Regul Toxicol Pharmacol; 2005 Aug; 42(3):296-312. PubMed ID: 15979221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the cancer risk to humans resulting from the presence of cyclophosphamide and ifosfamide in surface water.
    Kümmerer K; Al-Ahmad A
    Environ Sci Pollut Res Int; 2010 Feb; 17(2):486-96. PubMed ID: 19548016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
    Cunningham VL; Binks SP; Olson MJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping human health risks from exposure to trace metal contamination of drinking water sources in Pakistan.
    Bhowmik AK; Alamdar A; Katsoyiannis I; Shen H; Ali N; Ali SM; Bokhari H; Schäfer RB; Eqani SA
    Sci Total Environ; 2015 Dec; 538():306-16. PubMed ID: 26312405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring emerging contaminants in the drinking water of Milan and assessment of the human risk.
    Riva F; Castiglioni S; Fattore E; Manenti A; Davoli E; Zuccato E
    Int J Hyg Environ Health; 2018 Apr; 221(3):451-457. PubMed ID: 29366558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Health Relevance of Pharmaceutically Active Compounds in Drinking Water.
    Khan U; Nicell J
    AAPS J; 2015 May; 17(3):558-85. PubMed ID: 25739816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.